For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the arrival of this treatment and the formulated version represents a genuine breakthrough . These innovative therapies stabilize the transthyretin protein, slowing its harmful build-up and alleviatin